Advertisement
Advertisement
June 28, 2022
Reflow Medical Completes Enrollment in DEEPER LIMUS Trial of Temporary Spur Stent System
June 28, 2022—Reflow Medical, Inc. announced it has completed enrollment in the DEEPER LIMUS clinical trial to evaluate the company’s Temporary Spur stent system, which is designed to treat long, diffuse, and severely calcified infrapopliteal disease. The system allows for uniform expansion of the stent to maximize lumen diameter and may reduce acute vessel recoil and dissections, noted the company. 
According to the company, the Temporary Spur stent system is engineered to fulfill an unmet clinical need in treating patients with critical limb ischemia. The device consists of a retrievable nitinol stent system with radially expandable spikes—“spurs”—designed to create channels for increased uptake of antiproliferative limus-based drugs into the vessel wall. The system is then recaptured and removed, without leaving anything behind.
Marianne Brodmann, MD, who is a professor and vascular specialist at the Medical University of Graz in Austria, serves as Principal Investigator for the study.
“We were impressed from the start with the acute luminal gain we were able to achieve,” commented Dr. Brodmann in Reflow Medical’s press release. “It’s eye opening how the vessel responds. The device is also intuitive and easy to use.”
Advertisement
Advertisement
